News | January 18, 2013

CardioMEMS Inc. Wins 2012 Intel Innovation Award

January 18, 2013 — CardioMEMS Inc. was honored as the 2012 recipient of the Intel Innovation Award. Founder and CEO Jay Yadav, M.D., was presented with the award on Dec. 4, 2012 during the annual Health IT Leadership Summit held at the historic Fox Theatre in Atlanta, Ga.

The implantable wireless sensing and communication technology is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. The miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients. Due to their small size, durability, and lack of wires and batteries, our sensors are designed to be permanently implanted into the cardiovascular system. Using radiofrequency, or RF, energy, our sensors transmit real-time data to an external electronics module, which then communicates this information to the patient’s physician.

"CardioMEMS unites two areas where Georgia has strengths — health IT and medical devices," said David B. Hartnett, vice president, Bioscience and Health IT Development, Metro Atlanta Chamber. "This truly innovative company integrates these two disciplines to create advanced technology that holds huge promise for heart failure patients. We are proud that they are part of the Atlanta healthcare community, and look forward to watching their continued success."

"It was a challenging decision, given the high level of competition for this award," said Dan Rivera, area director, Intel Americas. "Ultimately, CardioMEMS was chosen as the winner based on its ground-breaking technology and novel use of health IT to reduce the burden on our healthcare system."

"We are honored to be recognized by Intel, a leader in innovative solutions," said Yadav. "This is a testament to the extraordinary efforts of the CardioMEMS team to generate precise, timely, actionable information to address the tremendous burden heart failure places on the U.S. healthcare system and on patients suffering from this debilitating disease. We are fortunate to have the considerable support of the Technology Association of Georgia, the Metro Atlanta Chamber and the Georgia Department of Economic Development as we continue to bring CardioMEMS' revolutionary technology to market."

For more information: www.cardiomems.com


Related Content

News | ECG

November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem ...

Home November 21, 2023
Home
News | ECG

October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...

Home October 13, 2023
Home
News | ECG

October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...

Home October 13, 2023
Home
News | ECG

September 26, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 26, 2023
Home
News | ECG

September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

Home September 06, 2023
Home
News | ECG

August 15, 2023 — Clario, a healthcare research technology company that delivers leading endpoint technology solutions ...

Home August 15, 2023
Home
News | ECG

July 27, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

Home July 27, 2023
Home
News | ECG

June 21, 2023 — Anumana, Inc., a leading AI-driven health technology company, has received Breakthrough Device ...

Home June 21, 2023
Home
News | ECG

June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking ...

Home June 19, 2023
Home
News | ECG

June 9, 2023 — Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for ...

Home June 09, 2023
Home
Subscribe Now